Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 oct. 2018 11h21 HE | Source: Oklahoma Medical Research Foundation

Oblato acquires all rights to glioblastoma drug from OMRF

OKLAHOMA CITY, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Oblato, Inc., has acquired all rights from the Oklahoma Medical Research Foundation to OKN-007, an investigational drug for the treatment of...
13 févr. 2018 15h02 HE | Source: Oklahoma Medical Research Foundation

Novel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood Products

OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation has entered a license agreement with Shanghai RAAS Blood Products Co., Ltd. Under the agreement, Shanghai...
27 nov. 2017 15h23 HE | Source: Progentec Diagnostics, Inc.

New tools for predicting lupus flares now one step closer to market

OKLAHOMA CITY, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Lead investor i2E, along with Chicago-based OCA Ventures and Mayo Clinic Ventures, has funded the first round of investment to assist Progentec in...